# Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)

> **NIH NIH U24** · DUKE UNIVERSITY · 2022 · $1

## Abstract

ABSTRACT
The Helping to End Addiction Long-term (HEAL) initiative was developed to identify scientific solutions to the
national opioid public health crisis as quickly as possible. As part of this initiative, the NIH HEAL Pain
Management Effectiveness Research Network (HEAL Pain ERN), will use the infrastructure of the NCATS Trial
Innovation Network to provide scientific guidance and coordination of the HEAL Pain ERN Trials. Specifically,
the three Trial Innovation Centers (TICs) at Duke/Vanderbilt, University of Utah and Johns Hopkins/Tufts will
provide integrated functions for the clinical coordinating center (CCC), data coordinating center (DCC), and
biostatistics core for the HEAL Pain ERN. Five HEAL Pain ERN trials will be selected which will require full
support from the HEAL Pain ERN CCC, DCC, and biostatistics core. In addition, network-based HEAL
initiative projects within the MFMU, NCORP, and PRISM will require partial select support from the HEAL Pain
ERN CCC, DCC, and biostatistics core.
The Duke/Vanderbilt Trial Innovation Center is poised to:
Specific Aim 1. Provide clinical trial leadership and expertise, assistance in study and protocol design, study
implementation, and management, in collaboration with the other two Trial Innovation Centers.
Specific Aim 2. Serve as the clinical coordinating center (CCC) for the HEAL Pain ERN trials.
Specific Aim 3. Provide single IRB support for two HEAL Pain ERN trials.
Specific Aim 4. Collaborate with the MFMU, PRISM, and NCORP HEAL initiative projects and provide specific
assistance requested by the project investigators, NCATS, project coordinating centers, and the funding
institute.
Through completion of these specific aims, we will harmonize the HEAL studies to achieve major innovations
in trial design and execution, including: combination and reuse of valuable data, efficiencies of implementation,
shared pain expertise among investigative teams, and the integration of three TICs as a cohesive unit, poised
for future trial implementation.

## Key facts

- **NIH application ID:** 10679811
- **Project number:** 3U24TR001608-07S2
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** DANIEL K. BENJAMIN
- **Activity code:** U24 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1
- **Award type:** 3
- **Project period:** 2022-09-23 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10679811

## Citation

> US National Institutes of Health, RePORTER application 10679811, Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT) (3U24TR001608-07S2). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10679811. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*